Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Semin Arthritis Rheum. 2015 Mar 3;45(1):70–74. doi: 10.1016/j.semarthrit.2015.02.010

Table 2.

a. Rate of Hospitalization for Specific CCS Chapters of Patients with Giant Cell Arteritis (GCA) and Patients without GCA

CCS Chaptersb GCA Ratec Non-GCA Ratec Rate Ratio (95% CI)
Infections, Parasitic 1.0 1.1 0.96 (0.49, 1.87)
Neoplasms 2.3 2.2 1.05 (0.67, 1.65)
Endocrine, Metabolic 1.9 1.4 1.37 (0.80, 2.37)
Mental 1.9 1.6 1.17 (0.70, 1.97)
Nervous, Sense Organs 2.1 1.2 1.71 (1.01, 3.04)
Circulatory 15.0 14.9 1.01 (0.84, 1.20)
Respiratory 4.3 6.3 0.67 (0.50, 0.91)
Digestive 5.4 4.3 1.24 (0.91, 1.70)
Genitourinary 2.1 1.2 1.76 (1.04, 3.12)
Skin, Subcutaneous 0.7 1.0 0.67 (0.30, 1.39)
Musculoskeletal, Connective Tissue 4.1 2.9 1.44 (1.00, 2.10)
Injury, Poisoning 5.6 4.1 1.38 (1.01, 1.89)
Symptoms and Ill-defined conditions 2.7 1.6 1.75 (1.10, 2.88)
a

Statistically significant results are presented in bold font.

b

Results for the following CCS chapters were not shown due to fewer than 10 total hospitalizations in the GCA cases: diseases of the blood and blood forming organs; complications of pregnancy (females only); congenital anomalies; certain conditions originating in the perinatal period; and residual codes/unclassified.

c

Rate of hospitalizations per 100 person-years.